Policy statement - Rabies-prevention policy update: New reduced-dose schedule

Michael T. Brady, Henry H. Bernstein, Carrie L. Byington, Kathryn M. Edwards, Margaret C. Fisher, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, David W. Kimberlin, Yvonne A. Maldonado, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby

Research output: Contribution to journalShort surveypeer-review

8 Scopus citations


The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.

Original languageEnglish (US)
Pages (from-to)785-787
Number of pages3
Issue number4
StatePublished - Apr 2011


  • Bites and stings
  • Guidelines
  • Immunization
  • Immunization schedule
  • Passive
  • Prevention and control
  • Rabies
  • Vaccines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Policy statement - Rabies-prevention policy update: New reduced-dose schedule'. Together they form a unique fingerprint.

Cite this